Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
12/22/2011 | WO2011158833A1 Agent for treating hcv infection |
12/22/2011 | WO2011158211A1 Use of substituted perylenes in organic solar cells |
12/22/2011 | WO2011158044A2 Respiratory formulations and compounds for use therein |
12/22/2011 | WO2011157688A1 Substituted triazolopyridines |
12/22/2011 | WO2011157346A1 Compounds for electronic devices |
12/22/2011 | WO2011073997A3 Process for preparing paliperidone and pharmaceutically acceptable salts thereof |
12/22/2011 | US20110313165 Quinolizidine and indolizidine derivatives |
12/22/2011 | US20110313164 Lithium derivatives of pyrroloquinoline quinone and preparation method thereof |
12/22/2011 | US20110313153 5-ht4 inhibitors for treating airway diseases, in particular asthma |
12/22/2011 | US20110312996 Novel inhibitors of hepatitis c virus replication |
12/22/2011 | US20110312994 Biphenyl derivatives |
12/22/2011 | US20110312992 Inhibitors of C-Kit and Uses Thereof |
12/22/2011 | US20110312989 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
12/22/2011 | US20110312987 Salt of naphthyridine carboxylic acid derivative |
12/22/2011 | US20110312975 Certain chemical entities, compositions and methods |
12/22/2011 | US20110312960 Pyrazine derivatives and use as pi3k inhibitors |
12/22/2011 | US20110312959 Derivatives of Azaindoles as Inhibitors of Protein Kinases ABL and SRC |
12/22/2011 | US20110312957 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors |
12/22/2011 | US20110312951 C-Ring Modified Tricyclic Benzonaphthiridinone Protein Kinase Inhibitors and Use Thereof |
12/22/2011 | US20110312950 CYCLIC INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1 |
12/22/2011 | US20110312940 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (p13-kinases) inhibitor |
12/22/2011 | US20110312939 New chemical compounds |
12/22/2011 | US20110312938 Pyrrolopyridine Carboxylic Acid Derivatives |
12/22/2011 | US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2 |
12/22/2011 | US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents |
12/22/2011 | US20110312934 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
12/22/2011 | US20110312908 Small molecule myristate inhibitors of bcr-abl and methods of use |
12/22/2011 | US20110312880 Potent chimeric nrti-nnrti bifunctional inhibitors of hiv-1 reverse transcriptase |
12/22/2011 | US20110312093 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
12/22/2011 | US20110311516 Chemically Programmed Vaccination |
12/22/2011 | US20110311482 Hepatitis C Virus Inhibitors |
12/22/2011 | US20110311474 Novel Tricyclic Compounds |
12/22/2011 | US20110309348 Organic light-emitting device |
12/22/2011 | US20110309338 Materical for organic electroluminescent devices and organic electroluminescent devices made by using the same |
12/22/2011 | DE102010024335A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices |
12/22/2011 | CA2805406A1 Growth hormone secretatogue receptor antagonists and uses thereof |
12/22/2011 | CA2802629A1 Substituted triazolopyridines |
12/22/2011 | CA2802477A1 Agent for treating hcv infection |
12/22/2011 | CA2802188A1 D2 antagonists, methods of synthesis and methods of use |
12/22/2011 | CA2801934A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
12/21/2011 | EP2397477A1 Heterocyclic-substituted piperidine compounds and the uses thereof |
12/21/2011 | EP2396327A1 Histamine h3 inverse agonists and antagonists and methods of use thereof |
12/21/2011 | EP2396326A1 Spiroindolinone pyridine derivative |
12/21/2011 | EP2396325A1 Derivatives of azaindoles as inhibitors of protein kinases abl and src |
12/21/2011 | EP2396324A1 Ý1, 2, 4¨triazolo ý1, 5 -a¨pyridines as kinase inhibitors |
12/21/2011 | EP2396323A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1 |
12/21/2011 | EP2396322A1 2-morpholino-pyridoý3,2-d¨pyrimidines |
12/21/2011 | EP2396315A1 Fused pyridine and pyrazine derivatives as kinase inhibitors |
12/21/2011 | EP2395992A2 Chemically programmed vaccination |
12/21/2011 | EP2173747B1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
12/21/2011 | EP2069346B1 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof |
12/21/2011 | EP1838709B1 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
12/21/2011 | EP1326841B1 Pyridinone derivatives for treatment of atherosclerosis |
12/21/2011 | CN1738817B 玻璃体结合蛋白受体的新的拮抗剂衍生物,它们的制备方法,它们作为药物的应用和包含它们的药物组合物 Vitronectin receptor antagonists new derivatives, processes for their preparation, their use as medicaments and pharmaceutical compositions containing them |
12/21/2011 | CN102292337A 螺吲哚满酮衍生物前药 Spiro indolinone derivative prodrugs |
12/21/2011 | CN102292336A 二氮杂二环壬基嘧啶衍生物的n-氧化物及它们的医药用途 N- oxide diazabicyclo nonyl pyrimidine derivatives and their pharmaceutical use |
12/21/2011 | CN102292323A 芳基甲基苯并喹唑啉酮m1受体正向变构调节剂 Aryl methylbenzo -quinazolinon m1 receptor positive allosteric modulator |
12/21/2011 | CN102286278A 一种2,3,5,6,7,8-六取代咪唑[1,2-a]吡啶类荧光材料及其合成方法 One kind 2,3,5,6,7,8- six substituted imidazole [1,2-a] pyridine-based fluorescent material and its synthesis method |
12/21/2011 | CN102285987A 氧化苦参碱制备新工艺 Preparation of new technology Oxymatrine |
12/21/2011 | CN102285986A 一种工业化纯化莫西沙星的方法 A method of purification of industrial moxifloxacin |
12/21/2011 | CN102285985A 10-羟基吡喹酮的制备及其作为抗血吸虫药物的应用 Preparation of 10-hydroxy praziquantel against Schistosoma japonicum and their use as drugs |
12/21/2011 | CN101798306B 钩藤生物碱单体的用途 Uses Uncaria alkaloid monomers |
12/21/2011 | CN101704817B 苦参碱类化合物及其制备方法与应用 Matrine compound and its preparation method and application |
12/20/2011 | US8080666 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
12/20/2011 | US8080662 Method of preparing 4-amino-1H-imidazo (4,5-c) quinolines and acid addition salts thereof |
12/20/2011 | US8080658 Material for organic electroluminescent element and organic electroluminescent element employing the same |
12/20/2011 | US8080547 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
12/20/2011 | US8080546 Pyrazolo-pyridinone derivatives and methods of use |
12/20/2011 | US8080544 Prodrugs of CGRP receptor antagonists |
12/15/2011 | WO2011156786A2 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
12/15/2011 | WO2011156780A2 8-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
12/15/2011 | WO2011156775A2 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
12/15/2011 | WO2011156655A2 Novel glp-1 receptor stabilizers and modulators |
12/15/2011 | WO2011156646A2 6-(sulfonylaryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
12/15/2011 | WO2011156640A2 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS |
12/15/2011 | WO2011156554A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
12/15/2011 | WO2011156245A2 Positive allosteric modulators of mglur2 |
12/15/2011 | WO2011154738A1 Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract |
12/15/2011 | WO2011154737A1 Morpholino pyrimidines and their use in therapy |
12/15/2011 | WO2011154678A1 Compounds |
12/15/2011 | WO2011153588A1 Viral polymerase inhibitors |
12/15/2011 | US20110306765 Stereoselective hydrogenation of a ketone |
12/15/2011 | US20110306631 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancer |
12/15/2011 | US20110306626 Imidazolinone derivatives as cgrp receptor antagonists |
12/15/2011 | US20110306612 Quinazolinone, quinolone and related analogs as sirtuin modulators |
12/15/2011 | US20110306604 3- and 6-quinolines with n-attached heterocyclic cgrp receptor antagonists |
12/15/2011 | US20110306603 Large substituent, non-phenolic opioids and methods of use thereof |
12/15/2011 | US20110306599 Indole compounds and pharmaceutical use thereof |
12/15/2011 | US20110306597 Nicotinamide Derivatives |
12/15/2011 | US20110306592 Cyclohexyl-azetidinyl antagonists of ccr2 |
12/15/2011 | US20110306560 Boronic ester and acid compounds, synthesis and uses |
12/15/2011 | US20110306542 Novel glp-1 receptor stabilizers and modulators |
12/15/2011 | US20110305636 Compounds, compositions, methods of synthesis, and methods of treatment |
12/15/2011 | US20110305618 Method for synthesis of a radionuclide-labeled compound using an exchange resin |
12/15/2011 | CA2802010A1 Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract |
12/15/2011 | CA2801909A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
12/15/2011 | CA2800203A1 Morpholino pyrimidines and their use in therapy |
12/14/2011 | EP2395573A1 Organic electroluminescent element, and illumination device and display device each comprising the element |
12/14/2011 | EP2395004A2 Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors |
12/14/2011 | EP2394995A1 Ring-fused 2-pyridone derivatives and herbicides |